↓ Skip to main content

Is Yttrium-90 Radioembolization a Viable Treatment Option for Unresectable, Chemorefractory Colorectal Cancer Liver Metastases? A Large Single-Center Experience of 302 Patients

Overview of attention for article published in Annals of Surgical Oncology, October 2014
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
62 Dimensions

Readers on

mendeley
64 Mendeley
Title
Is Yttrium-90 Radioembolization a Viable Treatment Option for Unresectable, Chemorefractory Colorectal Cancer Liver Metastases? A Large Single-Center Experience of 302 Patients
Published in
Annals of Surgical Oncology, October 2014
DOI 10.1245/s10434-014-4164-x
Pubmed ID
Authors

Akshat Saxena, Baerbel Meteling, Jada Kapoor, Sanjeev Golani, David L. Morris, Lourens Bester

Abstract

We report the largest series to date on the safety and efficacy of yttrium-90 (90Y) radioembolization for the treatment of unresectable, chemorefractory colorectal cancer liver metastases (CRCLM).

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 3%
Brazil 2 3%
Unknown 60 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 19%
Other 9 14%
Student > Ph. D. Student 7 11%
Student > Postgraduate 6 9%
Professor 5 8%
Other 9 14%
Unknown 16 25%
Readers by discipline Count As %
Medicine and Dentistry 31 48%
Nursing and Health Professions 4 6%
Business, Management and Accounting 2 3%
Arts and Humanities 1 2%
Biochemistry, Genetics and Molecular Biology 1 2%
Other 3 5%
Unknown 22 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 February 2015.
All research outputs
#18,395,895
of 22,786,087 outputs
Outputs from Annals of Surgical Oncology
#4,969
of 6,458 outputs
Outputs of similar age
#184,796
of 258,418 outputs
Outputs of similar age from Annals of Surgical Oncology
#68
of 103 outputs
Altmetric has tracked 22,786,087 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,458 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one is in the 15th percentile – i.e., 15% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 258,418 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 103 others from the same source and published within six weeks on either side of this one. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.